Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ozone as a Next-Generation Sterilization Process in Tissue Engineering and Regenerative Medicine: Critically Bridging Product Stability, Safety and Clinical Translation.

Molecules (Basel, Switzerland)·2026
Same author

Nanotechnology-based strategies for ROS-mediated anticancer and antimicrobial therapies.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Contact-Dependent Antibacterial Performance of Silver Nanoparticles Encapsulated in Collagen-Based Gels.

Journal of functional biomaterials·2026
Same author

A Critical Review of Commercial Collagen-Based Scaffolds in Bone Regeneration: Functional Properties and Clinical Evidence from Infuse<sup>®</sup> Bone Graft.

Journal of functional biomaterials·2025
Same author

Fluorogenic Platform for Real-Time Imaging of Subcellular Payload Release in Antibody-Drug Conjugates.

Journal of the American Chemical Society·2025
Same author

Model-based study of Yarrowia lipolytica cultivation on crude glycerol under different fermentation modes: Development of a membrane bioreactor process.

Bioresource technology·2024

Related Experiment Video

Updated: Jun 25, 2026

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self&#45;Assembling Peptide Matrix
10:23

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Bioproduction and characterization of a pH responsive self-assembling peptide

Jessica M Riley1, Amalia Aggeli, Rudolf J Koopmans

  • 1Astbury Centre for Structural Molecular Biology, Institute of Molecular and Cellular Biology, School of Chemistry, University of Leeds, Leeds LS2 9JT, UK.

Biotechnology and Bioengineering
|March 7, 2009
PubMed
Summary

Researchers developed a cost-effective method to produce the self-assembling peptide P(11)-4 using Escherichia coli. This recombinant peptide forms pH-dependent hydrogels, advancing nanoscale materials for tissue engineering.

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Formation of Ordered Biomolecular Structures by the Self-assembly of Short Peptides
07:26

Formation of Ordered Biomolecular Structures by the Self-assembly of Short Peptides

Published on: November 21, 2013

Related Experiment Videos

Last Updated: Jun 25, 2026

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self&#45;Assembling Peptide Matrix
10:23

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Formation of Ordered Biomolecular Structures by the Self-assembly of Short Peptides
07:26

Formation of Ordered Biomolecular Structures by the Self-assembly of Short Peptides

Published on: November 21, 2013

Area of Science:

  • Biomaterials Science
  • Synthetic Biology
  • Nanotechnology

Background:

  • Peptide P(11)-4 self-assembles into beta-sheets and nematic gels in a specific pH range.
  • Its biocompatibility and biodegradability make it suitable for tissue engineering applications.
  • High cost of chemical synthesis limits large-scale peptide production.

Purpose of the Study:

  • To develop a scalable and cost-effective method for producing peptide P(11)-4.
  • To characterize the self-assembly properties of the recombinant peptide.
  • To explore its potential in nanoscale material fabrication.

Main Methods:

  • Expression of peptide P(11)-4 repeats in Escherichia coli using the pET31b+ vector.
  • Utilized auto-induction growth medium for enhanced protein expression.
  • Inclusion body recovery, cyanogen bromide cleavage, and reverse-phase HPLC for purification.

Main Results:

  • Successfully produced 2.5 g/L of fusion protein using auto-induction.
  • Purified recombinant peptide P(11)-4 (rP(11)-4(hsl)) was obtained.
  • Recombinant peptide demonstrated pH-dependent hydrogel formation, beta-structure, and fibril formation.

Conclusions:

  • Recombinant production in E. coli offers a scalable alternative to chemical synthesis for P(11)-4.
  • The purified peptide retains its self-assembly properties and potential for biomaterial applications.
  • This method facilitates the use of P(11)-4 in tissue engineering and nanotechnology.